Sanofi to help produce millions of doses of the Pfizer/BioNTech vaccine

Sanofi, a French Pharma group, has agreed to produce 125 million doses of the Pfizer/BioNTech Coronavirus vaccine, a rare collaboration in the industry. Sanofi's own vaccine did not show sufficient results in December.

Head of Sanofi France Olivier Bogillot: "We looked at how we could show solidarity. When you look at the technological and industrial capacities of Sanofi, our expertise, I'm very proud that Sanofi has made this choice."